Evidence map›Paper›PMID 32405324›Full record

ArticleCardiovascular therapeutics2020

Therapeutic Anticoagulation with Argatroban and Heparins Reduces Granulocyte Migration: Possible Impact on ECLS-Therapy?

Andre Bredthauer, Manuel Kopfmueller, Michael Gruber, Sophie-Marie Pfaehler, Karla Lehle, Walter Petermichl, Timo Seyfried, Diane Bitzinger, Andreas Redel

Open access · goldAbstract read
In one paragraph

Article in Cardiovascular therapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Andre BredthauerDepartment of Anesthesiology, University Medical Center Regensburg, Regensburg, Germany.ORCID https://orcid.org/0000-0002-5779-7714
Manuel KopfmuellerDepartment of Anesthesiology, University Medical Center Regensburg, Regensburg, Germany.
Michael GruberDepartment of Anesthesiology, University Medical Center Regensburg, Regensburg, Germany.ORCID https://orcid.org/0000-0002-5509-9760
Sophie-Marie PfaehlerDepartment of Anesthesiology, University Medical Center Regensburg, Regensburg, Germany.
Karla LehleDepartment of Cardiothoracic Surgery, University Medical Center Regensburg, Regensburg, Germany.
Walter PetermichlDepartment of Anesthesiology, University Medical Center Regensburg, Regensburg, Germany.
Timo SeyfriedDepartment of Anesthesiology, University Medical Center Regensburg, Regensburg, Germany.
Diane BitzingerDepartment of Anesthesiology, University Medical Center Regensburg, Regensburg, Germany.ORCID https://orcid.org/0000-0002-3080-9957
Andreas RedelDepartment of Anesthesiology, University Medical Center Regensburg, Regensburg, Germany.
University Hospital Regensburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAnticoagulants such as argatroban and heparins (low-molecular-weight and unfractionated) play an immense role in preventing thromboembolic complications in clinical practice. Nevertheless, they can also have a negative effect on the immune system. This study is aimed at investigating the influence of these substances on polymorphonuclear neutrophils (PMNs), whose nonspecific defense mechanisms can promote thrombogenesis.

methodsBlood samples from 30 healthy volunteers were investigated, whereby PMNs were isolated by density gradient centrifugation and incubated with 0.8

resultsAll three anticoagulants led to significantly reduced PMN track lengths, with UFH having the biggest impact. The number of tracks observed in the UFH group were significantly reduced compared to the control group. Additionally, the UFH group demonstrated a significantly lower track straightness compared to the control. ROS production and NET formation were unaffected.

conclusionOur data provide evidence that anticoagulants have an inhibitory effect on the extent of PMN migration and chemotactic migration efficiency, thus indicating their potential immune-modulatory and prothrombotic effects.

Indexed as

AdultAnticoagulantsAntithrombinsArginineChemotaxis, LeukocyteEnoxaparinExtracellular TrapsFemaleGranulocytesHumansMaleMiddle AgedPipecolic AcidsReactive Oxygen SpeciesSulfonamidesYoung AdultAnticoagulantsAntithrombinsargatrobanArginineEnoxaparinPipecolic AcidsReactive Oxygen SpeciesSulfonamides

Identifiers

PMID32405324
PMCPMC7196999
OpenAlexW3020123822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.